Crossmark

Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: a pragmatic multicenter, prospective, randomized, controlled study Reply to letter to the editor

Crossref DOI link: https://doi.org/10.1007/s10072-022-06405-0

Published Online: 2022-09-14

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ferlazzo, Edoardo

Gasparini, Sara

Giussani, Giorgia

Bianchi, Elisa

Aguglia, Umberto https://orcid.org/0000-0002-4574-2951
License Information

Text and Data Mining valid from 2022-09-14

Version of Record valid from 2022-09-14
More Information

Article History

Received: 20 August 2022

Accepted: 9 September 2022

First Online: 14 September 2022

Declarations

:

: Research involving human participants and/or animals: not applicable (response to a Letter to the Editor).

: None.

Document is current

Any future updates will be listed below